Prosthetic Joint Infections Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: P7DCAD0A7470EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Prosthetic Joint Infections Treatment in Global, including the following market information:

Global Prosthetic Joint Infections Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Prosthetic Joint Infections Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fusidic acid Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Prosthetic Joint Infections Treatment include Cempra Inc, Motif Bio Plc, Nabriva Therapeutics AG, Telephus Medical LLC and TenNor Therapeutics Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prosthetic Joint Infections Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prosthetic Joint Infections Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Prosthetic Joint Infections Treatment Market Segment Percentages, by Type, 2021 (%)
  • Fusidic acid
  • Lefamulin Acetate
  • MTF-101
  • TNP-2092
  • Others
Global Prosthetic Joint Infections Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Prosthetic Joint Infections Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Clinic
  • Others
Global Prosthetic Joint Infections Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Prosthetic Joint Infections Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prosthetic Joint Infections Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Prosthetic Joint Infections Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Cempra Inc
  • Motif Bio Plc
  • Nabriva Therapeutics AG
  • Telephus Medical LLC
  • TenNor Therapeutics Ltd
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prosthetic Joint Infections Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prosthetic Joint Infections Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PROSTHETIC JOINT INFECTIONS TREATMENT OVERALL MARKET SIZE

2.1 Global Prosthetic Joint Infections Treatment Market Size: 2021 VS 2028
2.2 Global Prosthetic Joint Infections Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Prosthetic Joint Infections Treatment Players in Global Market
3.2 Top Global Prosthetic Joint Infections Treatment Companies Ranked by Revenue
3.3 Global Prosthetic Joint Infections Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prosthetic Joint Infections Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prosthetic Joint Infections Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prosthetic Joint Infections Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Prosthetic Joint Infections Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Prosthetic Joint Infections Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Prosthetic Joint Infections Treatment Market Size Markets, 2021 & 2028
  4.1.2 Fusidic acid
  4.1.3 Lefamulin Acetate
  4.1.4 MTF-101
  4.1.5 TNP-2092
  4.1.6 Others
4.2 By Type - Global Prosthetic Joint Infections Treatment Revenue & Forecasts
  4.2.1 By Type - Global Prosthetic Joint Infections Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Prosthetic Joint Infections Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prosthetic Joint Infections Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Prosthetic Joint Infections Treatment Revenue & Forecasts
  5.2.1 By Application - Global Prosthetic Joint Infections Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Prosthetic Joint Infections Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Prosthetic Joint Infections Treatment Market Size, 2021 & 2028
6.2 By Region - Global Prosthetic Joint Infections Treatment Revenue & Forecasts
  6.2.1 By Region - Global Prosthetic Joint Infections Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Prosthetic Joint Infections Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Prosthetic Joint Infections Treatment Revenue, 2017-2028
  6.3.2 US Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.3.3 Canada Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.3.4 Mexico Prosthetic Joint Infections Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Prosthetic Joint Infections Treatment Revenue, 2017-2028
  6.4.2 Germany Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.4.3 France Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.4.4 U.K. Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.4.5 Italy Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.4.6 Russia Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.4.8 Benelux Prosthetic Joint Infections Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Prosthetic Joint Infections Treatment Revenue, 2017-2028
  6.5.2 China Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.5.3 Japan Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.5.4 South Korea Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.5.6 India Prosthetic Joint Infections Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Prosthetic Joint Infections Treatment Revenue, 2017-2028
  6.6.2 Brazil Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.6.3 Argentina Prosthetic Joint Infections Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue, 2017-2028
  6.7.2 Turkey Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.7.3 Israel Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Prosthetic Joint Infections Treatment Market Size, 2017-2028
  6.7.5 UAE Prosthetic Joint Infections Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Cempra Inc
  7.1.1 Cempra Inc Corporate Summary
  7.1.2 Cempra Inc Business Overview
  7.1.3 Cempra Inc Prosthetic Joint Infections Treatment Major Product Offerings
  7.1.4 Cempra Inc Prosthetic Joint Infections Treatment Revenue in Global Market (2017-2022)
  7.1.5 Cempra Inc Key News
7.2 Motif Bio Plc
  7.2.1 Motif Bio Plc Corporate Summary
  7.2.2 Motif Bio Plc Business Overview
  7.2.3 Motif Bio Plc Prosthetic Joint Infections Treatment Major Product Offerings
  7.2.4 Motif Bio Plc Prosthetic Joint Infections Treatment Revenue in Global Market (2017-2022)
  7.2.5 Motif Bio Plc Key News
7.3 Nabriva Therapeutics AG
  7.3.1 Nabriva Therapeutics AG Corporate Summary
  7.3.2 Nabriva Therapeutics AG Business Overview
  7.3.3 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Major Product Offerings
  7.3.4 Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue in Global Market (2017-2022)
  7.3.5 Nabriva Therapeutics AG Key News
7.4 Telephus Medical LLC
  7.4.1 Telephus Medical LLC Corporate Summary
  7.4.2 Telephus Medical LLC Business Overview
  7.4.3 Telephus Medical LLC Prosthetic Joint Infections Treatment Major Product Offerings
  7.4.4 Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue in Global Market (2017-2022)
  7.4.5 Telephus Medical LLC Key News
7.5 TenNor Therapeutics Ltd
  7.5.1 TenNor Therapeutics Ltd Corporate Summary
  7.5.2 TenNor Therapeutics Ltd Business Overview
  7.5.3 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Major Product Offerings
  7.5.4 TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue in Global Market (2017-2022)
  7.5.5 TenNor Therapeutics Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Prosthetic Joint Infections Treatment Market Opportunities & Trends in Global Market
Table 2. Prosthetic Joint Infections Treatment Market Drivers in Global Market
Table 3. Prosthetic Joint Infections Treatment Market Restraints in Global Market
Table 4. Key Players of Prosthetic Joint Infections Treatment in Global Market
Table 5. Top Prosthetic Joint Infections Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prosthetic Joint Infections Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prosthetic Joint Infections Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prosthetic Joint Infections Treatment Product Type
Table 9. List of Global Tier 1 Prosthetic Joint Infections Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prosthetic Joint Infections Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prosthetic Joint Infections Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prosthetic Joint Infections Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prosthetic Joint Infections Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Cempra Inc Corporate Summary
Table 31. Cempra Inc Prosthetic Joint Infections Treatment Product Offerings
Table 32. Cempra Inc Prosthetic Joint Infections Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Motif Bio Plc Corporate Summary
Table 34. Motif Bio Plc Prosthetic Joint Infections Treatment Product Offerings
Table 35. Motif Bio Plc Prosthetic Joint Infections Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Nabriva Therapeutics AG Corporate Summary
Table 37. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Product Offerings
Table 38. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Telephus Medical LLC Corporate Summary
Table 40. Telephus Medical LLC Prosthetic Joint Infections Treatment Product Offerings
Table 41. Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue (US$, Mn), (2017-2022)
Table 42. TenNor Therapeutics Ltd Corporate Summary
Table 43. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Product Offerings
Table 44. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Prosthetic Joint Infections Treatment Segment by Type in 2021
Figure 2. Prosthetic Joint Infections Treatment Segment by Application in 2021
Figure 3. Global Prosthetic Joint Infections Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prosthetic Joint Infections Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prosthetic Joint Infections Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prosthetic Joint Infections Treatment Revenue in 2021
Figure 8. By Type - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 12. US Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 24. China Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prosthetic Joint Infections Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prosthetic Joint Infections Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Cempra Inc Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Motif Bio Plc Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Nabriva Therapeutics AG Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Telephus Medical LLC Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. TenNor Therapeutics Ltd Prosthetic Joint Infections Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications